Novozymes A/S banner

Novozymes A/S
CSE:NSIS B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NSIS B
Watchlist
Price: 387.3 DKK 1.25% Market Closed
Market Cap: kr160.6B

Operating Margin

24.9%
Current
Declining
by 0.6%
vs 3-y average of 25.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
24.9%
=
Operating Income
kr4.5B
/
Revenue
kr17.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
24.9%
=
Operating Income
kr4.5B
/
Revenue
kr17.9B

Peer Comparison

Country Company Market Cap Operating
Margin
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
US
Sherwin-Williams Co
NYSE:SHW
78.8B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
12.1T JPY
Loading...
US
Ecolab Inc
NYSE:ECL
74.5B USD
Loading...
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
258.9B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
25B CHF
Loading...
US
PPG Industries Inc
NYSE:PPG
23.1B USD
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.1T INR
Loading...
US
Albemarle Corp
NYSE:ALB
21B USD
Loading...

Market Distribution

Higher than 80% of companies in Denmark
Percentile
80th
Based on 506 companies
80th percentile
24.9%
Low
-5 981.6% — 1.3%
Typical Range
1.3% — 16.3%
High
16.3% — 423.3%
Distribution Statistics
Denmark
Min -5 981.6%
30th Percentile 1.3%
Median 7.5%
70th Percentile 16.3%
Max 423.3%

Novozymes A/S
Glance View

Market Cap
160.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NSIS B Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
24.9%
=
Operating Income
kr4.5B
/
Revenue
kr17.9B
What is Novozymes A/S's current Operating Margin?

The current Operating Margin for Novozymes A/S is 24.9%, which is below its 3-year median of 25.6%.

How has Operating Margin changed over time?

Over the last 3 years, Novozymes A/S’s Operating Margin has decreased from 25.8% to 24.9%. During this period, it reached a low of 24.9% on Jan 1, 2024 and a high of 27.5% on Sep 30, 2021.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett